Archive · CNBC Markets
Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
ZAZTEK archives the headline, summary and publication date so the story stays findable. The full article remains the publisher's. Read it at CNBC Markets →